News

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine — the nation's only traditional ...
In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine ...
If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
A Department of Health and Human Services spokesperson called the move "a radical departure from past practices." ...
Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.
Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...
Moderna Inc. shares declined after the company’s first-quarter vaccine sales missed estimates and it disclosed a delay in the ...